Improving colorectal cancer treatment by remodeling the tumor microenvironment
We are developing a novel therapeutic that weakens the protective matrix surrounding tumors, exposes resistant cancer cells, and improves access for anticancer drugs and immune cells. Our two complementary programs advance it as a standalone treatment and through engineered beneficial bacteria that act locally within tumors.
What we do
Pyovita develops new treatments for colorectal cancer by targeting the protective environment surrounding tumors.
Our novel therapeutic is designed to remodel this barrier, expose protected cancer cells, and improve access for anticancer drugs and immune cells. We are advancing two complementary product candidates: a standalone therapeutic for combination with existing cancer treatments and an engineered bacterial therapy that produces the therapeutic locally and helps remodel the tumor microenvironment.